Abstract
The American Brachytherapy Society (ABS) and its membership seeks to benefit patients by promoting the highest possible standard for brachytherapy practice, support health care professionals through the encouragement of state of the art technology and education, promote clinical and laboratory research, and advocate for the socioeconomic aspects of brachytherapy. The 2017 ABS Annual Meeting took place is Boston, Massachusetts, United States from April 20–22, 2017. The theme “The Value of Brachytherapy in Multidisciplinary Cancer Care” drew a multitude of national and international speakers to present data and debate clinical indications, advancements in practice and the value of brachytherapy. With a focus on the advancement of brachytherapy for prostate cancer and the socioeconomic benefits of brachytherapy, the globally focused program hosted 93 speakers, 506 attendees, and exhibitors from 15 countries and featured 251 abstracts for presentation and display. The ABS Annual Meeting left attendees with initial data on timely and relevant topics such as outcomes following brachytherapy for recurrent prostate cancer following external beam radiotherapy, findings of prototype algorithms capable of rapidly generating prostate brachytherapy pre-operative treatment plans and results on the socioeconomic disparities impacting the utilization of brachytherapy for common malignancies. These novel findings, among many other thoughtful and thought-provoking presentations, gave meeting attendees knowledge of the current state of brachytherapy and future directions of the specialty.
Highlights
The Judith Stitt Best Abstract Award recipients are selected through the American Brachytherapy Society (ABS)’s meticulous scientific committee review process and the recipients’ abstracts are presented in the Annual Meeting’s plenary session
The authors found that their plans are comparable to the quality of plans which were simultaneously created by experts trained in brachytherapy (Figure 1) (1)
The group’s institutional experience found that patients treated with I125 eye plaque brachytherapy had similar local control and metastases rates and had better visual preservation in comparison to those outcomes reported by Collaborative Ocular Melanoma Studies (3)
Summary
Peter F., Cathryn Yashar, Dan Petereit, Firas Mourtada, Ann Klopp, David Gaffney, and Steven Frank. “2017 American Brachytherapy Society’s Annual Meeting Report.”. Translational Andrology and Urology 6 (5): 1005-1013.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
